Impact of Inflammatory Bowel Disease (IBD) and IBD Medications on Risk of Hyperlipidemia and in vitro Hepatic Lipogenic-Related Gene Expression: A Population-Based Cohort Study
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Medicine"
DOI: 10.3389/fmed.2022.910623
Abstract: Patients with inflammatory bowel disease (IBD) present a higher risk of developing cardiovascular diseases (CVDs) due to chronic inflammation, which plays an essential role in atherogenesis. Hyperlipidemia is another risk factor for CVDs; however, the… read more here.
Keywords: ibd; risk hyperlipidemia; medications risk; ibd medications ... See more keywords
Phenotype and outcomes of very early onset and early onset inflammatory bowel diseases in a Montreal pediatric cohort
Sign Up to like & getrecommendations! Published in 2023 at "Frontiers in Pediatrics"
DOI: 10.3389/fped.2023.1157025
Abstract: Objectives The incidence of very-early-onset inflammatory bowel disease (VEO-IBD) and early-onset IBD (EO-IBD) is increasing. Here, we report their phenotype and outcomes in a Montreal pediatric cohort. Methods We analyzed data from patients diagnosed with… read more here.
Keywords: ibd; onset inflammatory; early onset; veo ibd ... See more keywords